- No Data
English
- English
- 简体中文
- 繁体中文
- Français
- Русский
- Italiano
- 日本語
- 한국어
- Português
- Deutsch
- Español
- Türkçe
- Ελληνικά
- Nederlands
- Tiếng Việt
- Polski
Recently, the High Power Laser Unit Technology Laboratory of Shanghai Institute of Optics and Fine Mechanics, Chinese Academy of Sciences, has made progress in research on high efficiency supercontinuum in specific bands. The relevant research results were published in the Journal of Lightwave Technology under the title of "Strong Anti Stokes and flat supercontinuum in specified band based on non ...
Recently, Opton Laser International, a supplier specializing in photonics, is currently distributing manufacturer UltraFast Innovations (UFI)'s ultra-high contrast third-order autocorrelator Tundra++. The new generation Tundra aims to characterize the temporal intensity distribution and quality of laser pulses with particularly high sensitivity.This is to avoid the harmful effects caused by the hi...
According to reports, British scientists will build the world's largest power laser. They hope that this £ 85 million (approximately $103 million) device can accelerate the use of nuclear fusion and potentially obtain clean energy, which is inexhaustible.According to the report, the "Vulcan" 20-20 laser will be built in Havel, Oxfordshire, and it will produce a laser brightness that is 24 t...
The Mitsubishi GX-F Advanced series of artificial intelligence enabled fiber lasers now use patented gas and burr reduction technology to help improve cutting quality while reducing gas consumption when cutting low-carbon steel.Mitsubishi Laser's proprietary Agr Mix nozzle technology does not require an external mixing tank or high-pressure oxygen. The combination of low-pressure air and nitrogen ...
On July 3rd local time, Swiss ophthalmic care giant Alcon announced the acquisition of Israeli medical technology company Belkin Vision and its laser equipment assets for treating glaucoma.The transaction includes a prepayment of $81 million, of which approximately $65 million is in cash. In addition, if Alcon can establish this technology as the preferred first-line treatment option for clinical ...